ICICI Lombard General Insurance Company Ltd has reduced its contingent liabilities after the Customs, Excise & Service Tax Appellate Tribunal (CESTAT) allowed its appeals, setting aside significant tax demands and penalties. The orders pertain to appeals for periods ranging from FY2008-09 to FY2014-15. Consequently, the insurer confirmed there are no financial implications resulting from the earlier demands.

The company filed a revised intimation with BSE Limited and National Stock Exchange of India Limited on June 12, 2026, correcting details provided in its earlier disclosure dated June 10, 2026. The initial filing had listed service tax demands of ₹ 547.84 Million for FY2008-09 to FY2011-12, FY2013-14 & FY2014-15, and ₹ 593.44 Million for FY2011-12. It also included corresponding interest under section 75 of the Finance Act, 1994, and penalties matching the demand amounts.

Following the CESTAT orders, the company stated that the tax demand, interest, and penalty have been set aside. The revised disclosure confirms that the previously reported contingent liabilities have been reduced to the extent of the demands set aside.

The table below outlines the changes in the disclosure regarding the financial implications and penalties:

The company had previously disclosed the tax demands, including interest and penalty, as contingent liabilities in its financial statements. The revision was submitted by Vikas Mehra, Company Secretary, on June 12, 2026. All other information in the intimation dated June 10, 2026, remains unchanged.

ICICI Lombard General Insurance has received a sustained Buy recommendation from Motilal Oswal Securities (MOSL), with a target price of ₹2,240. The brokerage's conviction is anchored in the company's strong monetization of long-term investments and a broad-based operational momentum across its retail health and distribution segments.

Retail Health Growth and Distribution Expansion

A standout highlight in MOSL's assessment is ICICI Lombard General Insurance's industry-leading retail health growth of 51% YoY, which the brokerage attributes to a multi-pronged strategy encompassing distribution expansion, product innovation, and technology-led underwriting enhancements. The company has added 25,000 agents to its distribution network, significantly broadening its market reach and sales capabilities.

The following table summarizes the key investment thesis parameters cited by MOSL:

Technology and Customer Engagement

Beyond distribution, MOSL underscores the role of tech-led underwriting enhancements as a structural differentiator for ICICI Lombard General Insurance. These technological investments are seen as enabling more precise risk assessment and operational efficiency across the insurance value chain.

The company's customer engagement platform, IL Sahayak, has emerged as a key service delivery tool, now operational across 60 cities and integrated with a network of 3,000 hospitals. This wide-reaching platform is cited as a contributor to superior customer engagement and claims servicing capabilities.

Investment Rationale

MOSL's Buy stance reflects confidence in the company's ability to capitalize on its long-term strategic investments. The combination of robust retail health expansion, a growing agent network, product innovation, and a technology-driven approach to underwriting and customer service forms the core of the brokerage's positive assessment.

• 51% YoY retail health growth — industry-leading performance
• 25,000 agents added — strengthening distribution reach
• Tech-led underwriting — enhancing risk management and efficiency
• IL Sahayak — customer engagement across 60 cities and 3,000 hospitals
• Target Price: ₹2,240 with a Buy recommendation